Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities KROS - Keros Therapeutics, Inc.
179 M
LAST VALUE
150.36%
2 YEAR CAGR
73.26%
5 YEAR CAGR
0.00%
10 YEAR CAGR